Metabolic effects of darunavir/ritonavir versus atazanavir/ritonavir in treatment-naive, HIV type 1-infected subjects over 48 weeks. [electronic resource]
Producer: 20130219Description: 1184-95 p. digitalISSN:- 1931-8405
- Acquired Immunodeficiency Syndrome -- drug therapy
- Adult
- Aged
- Atazanavir Sulfate
- Biomarkers -- blood
- CD4 Lymphocyte Count
- Darunavir
- Disease Progression
- Drug Administration Schedule
- Drug Resistance, Viral
- Drug Therapy, Combination
- Female
- Glomerular Filtration Rate
- HIV Protease Inhibitors -- administration & dosage
- HIV-1 -- drug effects
- Humans
- Insulin Resistance
- Lipids -- blood
- Male
- Middle Aged
- Oligopeptides -- administration & dosage
- Pilot Projects
- Pyridines -- administration & dosage
- RNA, Viral -- blood
- Ritonavir -- administration & dosage
- Sulfonamides -- administration & dosage
- Time Factors
- Treatment Outcome
- Viral Load
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase IV; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.